The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial
Journal of Cosmetic Dermatology2019Vol. 19(1), pp. 167–172
Citations Over TimeTop 10% of 2019 papers
Mehdi Gheisari, Sahar Dadkhahfar, Elham Olamaei, Hamid Moghimi, Nasim Niknejad, Niloufar Najar Nobari
Abstract
Methimazole could be an alternative treatment of melasma alone or in combination with other depigmenting drugs. Although not as effective as hydroquinone, the noncytotoxic and nonmutagenic aspects of methimazole may make it a promising alternative for the treatment of melasma.
Related Papers
- → Melasma pathogenesis and influencing factors – an overview of the latest research(2012)138 cited
- → Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma(2019)134 cited
- → Study of autologous platelet‐rich‐plasma versus its combination with intense pulsed light in treatment of melasma(2021)10 cited
- → Laser toning for melasma: A single-centre experience with 38 970 cases(2016)8 cited
- → Melasma in Men(2015)1 cited